openPR Logo
Press release

Cultured Meat Market to Reach USD 229 Billion by 2050, Expanding at 31% CAGR | UPSIDE Foods, Mosa Meat, Aleph Farms

04-22-2026 03:59 PM CET | Health & Medicine

Press release from: Roots Analysis

Cultured Meat Market to Reach USD 229 Billion by 2050, Expanding

The global cultured meat market, valued at USD 0.27 billion in 2025, will reach USD 0.34 billion in 2026 and is on track to hit USD 229 billion by 2050, advancing at a compound annual growth rate (CAGR) of 31% over the 2026 to 2050 forecast period. Driven by mounting pressure on conventional protein supply chains, growing consumer demand for sustainable food alternatives, and accelerating regulatory approvals in key markets, the cultured meat industry now stands at an inflection point that few protein sectors have seen in a generation.

To explore the complete findings, request a free sample of the report at https://www.rootsanalysis.com/reports/cultured-meat-market/request-sample.html

Market Overview
Cultured meat, also called cultivated or cell-based meat, is produced by isolating stem cells from living animals and growing them in bioreactors using cell culture media. The process bypasses conventional slaughter entirely, delivering finished meat products with a fraction of the land, water, and greenhouse gas footprint of traditional livestock farming. With roughly 75% of global agricultural land currently dedicated to animal farming and approximately 60% of food-production greenhouse gas emissions tied to meat output, the scale of the problem is clear, and cultured meat addresses it at the source.

The world population is projected to reach 9.8 billion by 2050, according to United Nations estimates, placing extraordinary strain on protein supply systems. Conventional animal farming cannot meet that demand alone, and the environmental and ethical costs of scaling it further are widely considered unacceptable. Cultured meat fills that gap by offering nutritionally comparable products at scale, without the land burden, without the welfare concerns, and with the capacity to be produced near any urban center with access to bioprocessing infrastructure.

Investment activity confirms the commercial seriousness of the sector. Cultured meat companies have raised a cumulative total of more than USD 2.4 billion since 2020, with seed and venture capital funding accounting for the majority of financing rounds. The largest single deal on record is the USD 347 million Series B round closed by Believer Meats (formerly Future Meat Technologies) in December 2021, led by ADM, S2G Ventures, and Menora Mivtachim. Partnership activity is equally telling: more than 280 collaboration agreements have been inked since 2022, covering manufacturing, distribution, product development, and licensing. In April 2026, Brazilian meat giant JBS opened a USD 37 million facility to produce cultivated meat-based proteins targeting supplements and precision nutrition segments.

Key Growth Drivers
Surging Global Protein Demand. The single most powerful tailwind for this market is the widening gap between global protein demand and what livestock farming can supply. As incomes rise in Asia and Africa alongside population growth, per-capita meat consumption is climbing even faster than total population figures suggest. Cultured meat is positioned to absorb a growing share of that demand without requiring new agricultural land conversion or increases in livestock inventory.

Environmental Accountability Pressures. Governments, institutional investors, and large food companies are under mounting pressure to reduce scope 3 emissions from their supply chains. Conventional meat production accounts for an outsize share of agricultural emissions. Cultured meat, with its minimal land and water footprint and significantly lower greenhouse gas intensity, offers food companies a credible path to emissions reduction without reformulating their product lines.

Regulatory Progress in Key Markets. Regulatory milestones are removing one of the most significant barriers to commercial scale. The US Food and Drug Administration has granted safety clearances to cultivated chicken products. Singapore became the first country to authorize cultivated meat for human consumption, approving three distinct products in February 2026, including offerings from Vow and GOOD Meat. Each new regulatory clearance expands the addressable commercial market and signals to investors that the regulatory pathway is tractable.

Rising Ethical Consumerism. Consumer surveys across North America, Europe, and major Asia-Pacific markets consistently show growing willingness to try and pay a premium for products that eliminate animal welfare concerns. This shift, documented across multiple generations of consumer panels, is particularly pronounced among urban, younger demographics who represent the core early-adopter market for cultured meat products.

Intensifying IP and Technology Competition. More than 360 patents focused on cultured meat have been filed or granted in the past five years, with 88% of those still in application stage. This volume of intellectual property activity signals that companies are racing to lock in proprietary positions across cell lines, bioreactor design, scaffolding materials, and cell culture media formulations. Technology competition is accelerating the pace of process improvement and cost reduction simultaneously.

Market Segmentation: Poultry Leads, Pet Food Grows Fastest
By source of meat, poultry and pork together command the largest share of the cultured meat market and are expected to retain that position through 2050. Their nutritional density and broad consumer familiarity make them the preferred entry points for cultivated products. Beef and seafood follow, with cultivated seafood currently holding approximately 10% of total market share. By cultivation technique, scaffold-based methods lead the field because the scaffold structure provides a physical framework that guides tissue maturation into the defined, structured forms consumers expect in whole-cut products.

By form, minced meat occupies the larger segment because its relative structural simplicity makes it easier to produce at scale and formulate into high-volume end products such as burger patties and nuggets. Burger patties currently hold the largest share within minced meat, followed by nuggets. Whole-cut meat, though more technically demanding, is where premium differentiation will eventually be won. By application, the human food industry holds the greater current share, reflecting the regulatory approvals that have been granted for human consumption products. The pet food segment, however, is growing faster: regulatory requirements for pet products are less demanding, and the finished product does not require the three-dimensional bio-fabrication standards needed for human food. By end user, restaurants are the dominant channel today, followed by retailers and e-commerce.

To request quote of this report, please visit:
https://www.rootsanalysis.com/reports/cultured-meat-market/request-quote.html

Regional Insights: North America and Asia-Pacific Dominate, Europe Moves Fastest
North America and Asia-Pacific together account for more than 95% of the current cultured meat market, with North America's strength anchored in FDA regulatory progress and a dense cluster of well-funded startups. Approximately 30% of all profiled cultured meat companies are headquartered in North America. Asia-Pacific is projected to capture approximately 38% of the overall market by 2050, driven by growing meat demand in China, India, and Southeast Asia, combined with active government support for food technology innovation in Singapore and South Korea.

Europe is the fastest-growing region in the forecast, projected to expand at a CAGR of 87% through 2050. That figure reflects both a low current base and a substantial pipeline of planned production facility investments across the UK, Netherlands, and Germany. Within Europe, the UK has emerged as the primary hub of cultured meat company formation. Regulatory frameworks in the European Union are evolving, and as approvals follow, the region is expected to rapidly close the gap with North American and Asia-Pacific market shares.

Competitive Landscape
The cultured meat market features more than 105 active companies, with over 65% of them founded between 2018 and 2021, reflecting the wave of venture interest that followed early proof-of-concept milestones. Key profiled companies include Aleph Farms, Esco Aster, GOOD Meat, Mosa Meat, UPSIDE Foods, Vow, Ants Innovate, Blue Ridge Bantham, BLUU, Finless Foods, Meatiply, MIRAI FOODS, Newform Foods, Ohayo Valley, Steakholder Foods, and The Better Butchers, among a full roster of 109 companies covered in the report.

The competitive dynamic is currently defined by a race for regulatory clearance and production scale rather than pure pricing. Companies that secure early approvals and demonstrate the ability to produce at commercial volumes will establish durable moats. Acquisitions are already reshaping the field: JBS acquired Bio.Tech.Foods in May 2022 to access the company's protein production technology, a move that illustrates how incumbent meat processors are building positions in cultivated protein through M&A rather than organic R&D alone. Startups with proprietary cell lines and bio-fabrication processes hold significant technical advantages, but the gap between a lab-scale proof and a commercially viable production system remains the central challenge the sector is working to close.

Browse Full Report Description + Research Methodology + Table of Content + Infographics here:
https://www.rootsanalysis.com/reports/cultured-meat-market.html

Contact Details
Gaurav Chaudhary
Email: Gaurav.chaudhary@rootsanalysis.com or sales@rootsanalysis.com
Website: https://www.rootsanalysis.com

About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. All reports provided by us are structured in a way that enables the reader to develop a thorough perspective on the given subject. Apart from writing reports on identified areas, we provide bespoke research / consulting services dedicated to serve our clients in the best possible way.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Cultured Meat Market to Reach USD 229 Billion by 2050, Expanding at 31% CAGR | UPSIDE Foods, Mosa Meat, Aleph Farms here

News-ID: 4484363 • Views:

More Releases from Roots Analysis

Smart Inhalers Market to Reach USD 5.84 Billion by 2035, Growing at 12.95% CAGR | AstraZeneca, GlaxoSmithKline, Adherium Among Key Players
Smart Inhalers Market to Reach USD 5.84 Billion by 2035, Growing at 12.95% CAGR …
The global smart inhalers market, valued at USD 1.53 billion in 2024, is on course to reach USD 5.84 billion by 2035, expanding at a compound annual growth rate (CAGR) of 12.95% over the forecast period. The acceleration reflects a structural shift in respiratory care, as healthcare systems worldwide move from reactive treatment to data-driven disease management, backed by widespread adoption of connected medical devices and a sharply rising global
Global Pharmacy Market to Reach USD 4.1 Trillion by 2035, Growing at 5% CAGR | CVS Health, Walgreens Boots Alliance, Amazon Pharmacy
Global Pharmacy Market to Reach USD 4.1 Trillion by 2035, Growing at 5% CAGR | C …
The global pharmacy market, valued at USD 2.5 trillion in 2025, will reach USD 2.6 trillion in 2026 and climb to USD 4.1 trillion by 2035, advancing at a compound annual growth rate of 5% over the forecast period. This growth reflects a convergence of structural forces: the accelerating burden of chronic disease, the rapid digitalization of healthcare delivery, and a generational shift in how patients access, purchase, and manage
Probiotics Market to Reach $165.1 Billion by 2035, Growing at 8.0% CAGR | Nestlé, Danone, Yakult Honsha Among Key Players
Probiotics Market to Reach $165.1 Billion by 2035, Growing at 8.0% CAGR | Nestle …
The global probiotics market, valued at USD 70.9 billion in 2024, is on course to reach USD 76.2 billion in 2025 and USD 165.1 billion by 2035, expanding at a compound annual growth rate of 8.0% over the forecast period. Rising consumer investment in preventive health, the mainstreaming of functional foods, and accelerating research into next-generation microbial strains are collectively pushing this market beyond what was possible just five years
Contact Lenses Market to Reach USD 16.97 Billion by 2035, Growing at 39.7% CAGR | Johnson & Johnson, Alcon, Bausch + Lomb
Contact Lenses Market to Reach USD 16.97 Billion by 2035, Growing at 39.7% CAGR …
The global contact lenses market, valued at USD 0.60 billion in 2025, will expand to USD 16.97 billion by 2035, advancing at a compound annual growth rate (CAGR) of 39.7% over the forecast period. Surging rates of refractive disorders worldwide, accelerating innovation in drug-eluting and diagnostic lens technology, and a new wave of augmented reality (AR) applications are collectively reshaping what contact lenses can do, and what the market can

All 5 Releases


More Releases for USD

Bone Cement Market Outlook USD 1,871.10M-USD 3,512.31M
How Is the Bone Cement Market Supporting the Rise of Modern Orthopedic Surgery? The Bone Cement Market plays a critical role in modern orthopedic and spinal procedures, acting as a foundational material for joint replacement, fracture fixation, and vertebral stabilization. Bone cement is widely used to anchor implants, restore bone structure, and improve patient mobility-making it an essential component of musculoskeletal care. In 2025, the global bone cement market was valued at
Autologous Cell Therapy Market Outlook USD 9.31B-USD 54.83B
How Is the Autologous Cell Therapy Market Redefining the Future of Precision Medicine? The Autologous Cell Therapy Market is rapidly emerging as one of the most transformative areas in modern healthcare, offering highly personalized treatment options for complex and chronic diseases. By using a patient's own cells to repair, replace, or regenerate damaged tissues, autologous cell therapy minimizes immune rejection risks while maximizing therapeutic effectiveness. In 2025, the global autologous cell therapy
US Ostomy Care and Accessories Market USD 4.03B-USD 6.75B
How Is the United States Ostomy Care and Accessories Market Evolving to Meet the Needs of a Growing Patient Population? The United States Ostomy Care and Accessories Market plays a critical role in improving the quality of life for millions of patients who undergo life-altering surgical procedures involving the digestive or urinary systems. Ostomy care products are essential medical devices designed to manage bodily waste safely and discreetly following surgeries such
PACS Market USD 5.59B in 2025, USD 9.73B by 2035
Picture Archiving and Communication System (PACS) Market Expands as Digital Imaging Transforms Global Healthcare Introduction: PACS at the Core of Modern Medical Imaging The healthcare industry is undergoing a rapid digital transformation, with medical imaging playing a critical role in diagnosis, treatment planning, and patient monitoring. At the heart of this transformation lies the Picture Archiving and Communication System (PACS)-a technology that enables the storage, retrieval, management, and sharing of medical images
Global HEOR Market USD 1.70B-USD 6.03B
Health Economics and Outcomes Research (HEOR) Market Accelerates as Value-Based Healthcare Redefines Global Decision-Making Introduction: The Growing Importance of HEOR in Modern Healthcare The global healthcare industry is undergoing a profound transformation, shifting from volume-driven care models to value-based healthcare systems that prioritize patient outcomes, cost efficiency, and real-world effectiveness. At the center of this transformation lies Health Economics and Outcomes Research (HEOR)-a discipline that evaluates the economic value, clinical outcomes, and
Foam Tape Market Outlook 2035: Industry Growth from USD USD 4.89 Billion (2025) …
The Foam Tape Market plays a vital role in modern industrial and manufacturing ecosystems. Foam tapes are pressure-sensitive adhesive products manufactured using materials such as polyurethane, polyethylene, PVC, and acrylic foam. These tapes are widely used for bonding, sealing, insulation, cushioning, vibration damping, and noise reduction across multiple industries. Their ability to replace traditional mechanical fasteners like screws, bolts, and rivets has positioned foam tapes as a preferred solution in